Oracle stated on Wednesday that it plans to buy goBalto, a cloud platform company that specializes in clinical trails site selection and activation for life sciences companies. Apparently, with this purchase, Oracle wants to expand it's Health Sciences business. I was hoping to get some thoughts on this acquisition.
https://www.zdnet.com/article/oracle-buys-gobalto-to-expand-health-sciences-business/
Another appendage to strap onto the 1957 Edsel. It will make no difference.
Will destroy it on no time just like it destroyed all other acquisitions, PhaseForward which was in clinical trials included, was a market leader when acquired now trails behind b/c oracle did not invest and changed contract terms for the worse, in other words the usual MO
How much Oracle paid for it?
Another bolted-on service. NIH syndrome. Lather, rinse, repeat.